Aranesp is the trade name for Darbepoetin alfa, a synthetic version of erythropoietin, which stimulates the production of red blood cells. Aranesp has been used since its approval by the U.S. Food and Drug Administration (FDA) in 2001 to treat patients with anemia, as well as chronic renal failure. It has been frequently prescribed to individuals suffering anemia as a byproduct of chemotherapy.
The FDA has required black box warnings on all sales of Darbepoetin alfa in the United States, citing a number of potential adverse health risks, including:
If you experienced side effects after being prescribed Aranesp, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
The Supreme Court has undoubtedly lurched toward conservatism in the past 20 years, but death penalty cases have larg... Read More
What Are They? What Are the Eligibility Requirements? To obtain either temporary or permanent lawful residency in the ... Read More
Immigration Document Can Help Protect Foreign Workers in America Foreign nationals working in the United States can oft... Read More
How It Works